Zhang Tao, Pan Wenming, Huang Kai, Qiu Jun, Zhang Wei, Yang Jinhua
Department of Spine Surgery, Changshu No.2 People's Hospital, Changshu, Jiangsu, China.
Ann Med. 2025 Dec;57(1):2558122. doi: 10.1080/07853890.2025.2558122. Epub 2025 Sep 11.
Subclinical thyroid dysfunction (STD) is associated with an elevated risk of non-vertebral fractures. However, whether STD is associated with the risk of vertebral fracture remains controversial. This study aimed to determine the relationship between STD and the risk of vertebral fracture using a meta-analysis approach.
PubMed, Embase, and the Cochrane Library databases were searched for eligible studies published until March 01, 2025. Only prospective cohort studies that reported effect estimates with 95% confidence intervals (CIs) of vertebral fractures in participants with subclinical hyperthyroidism (SCH) and subclinical hypothyroidism (SH) compared to those with euthyroidism were included. A random-effects model was used to pool risk ratios (RRs), and analyses accounted for key covariates, including demographic factors, lifestyle variables, and disease history where reported.
Ten prospective cohort studies involving 61,219 individuals were included in this meta-analysis. SCH was associated with an increased risk of vertebral fracture (RR: 2.20; 95% CI: 1.60-3.02; < 0.001). Moreover, the risk of vertebral fracture in individuals with SH was higher than that in those with euthyroidism (RR, 1.22; 95% CI: 1.01-1.49; = 0.044). The pooled conclusions for the association between SCH and vertebral fracture risk were robust, whereas the significant association between SH and vertebral fracture was variable. The relationship between SH and vertebral fracture risk was affected by the median age of individuals ( = 0.047).
Our study found that SCH was an independent risk factor for vertebral fracture, and that SH may increase the risk of vertebral fracture. Clinically, these findings support the need for regular monitoring of thyroid function, particularly in older adults, to identify individuals with STD who may benefit from targeted interventions to reduce vertebral fracture risk.
亚临床甲状腺功能障碍(STD)与非椎体骨折风险升高相关。然而,STD是否与椎体骨折风险相关仍存在争议。本研究旨在采用荟萃分析方法确定STD与椎体骨折风险之间的关系。
检索了PubMed、Embase和Cochrane图书馆数据库,以查找截至2025年3月1日发表的符合条件的研究。仅纳入前瞻性队列研究,这些研究报告了亚临床甲状腺功能亢进(SCH)和亚临床甲状腺功能减退(SH)参与者与甲状腺功能正常者相比椎体骨折的效应估计值及95%置信区间(CI)。采用随机效应模型汇总风险比(RR),分析考虑了关键协变量,包括人口统计学因素、生活方式变量以及报告的疾病史。
本荟萃分析纳入了10项涉及61219人的前瞻性队列研究。SCH与椎体骨折风险增加相关(RR:2.20;95%CI:1.60 - 3.02;<0.001)。此外,SH个体的椎体骨折风险高于甲状腺功能正常者(RR,1.22;95%CI:1.01 - 1.49;=0.044)。SCH与椎体骨折风险之间关联的汇总结论较为稳健,而SH与椎体骨折之间的显著关联则存在差异。SH与椎体骨折风险之间的关系受个体中位年龄的影响(=0.047)。
我们的研究发现SCH是椎体骨折的独立危险因素,SH可能增加椎体骨折风险。临床上,这些发现支持对甲状腺功能进行定期监测的必要性,尤其是在老年人中,以识别可能从针对性干预中受益以降低椎体骨折风险的STD个体。